Your browser doesn't support javascript.
loading
Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?
Baklouti, S; Marolleau, S; Chavanet, P; Bonnet, E; Concordet, D; Gandia, P.
Affiliation
  • Baklouti S; Laboratoire de Pharmacocinétique et Toxicologie Clinique, Institut Fédératif de Biologie, CHU de Toulouse, Toulouse, France.
  • Marolleau S; INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France.
  • Chavanet P; INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France.
  • Bonnet E; Department d'Infectiologie, CHU de Dijon, Dijon, France.
  • Concordet D; Cabinet d'Infectiologie, Clinique Pasteur, Toulouse, France.
  • Gandia P; INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France.
Antimicrob Agents Chemother ; 66(1): e0149321, 2022 01 18.
Article in En | MEDLINE | ID: mdl-34662193
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teicoplanin / Anti-Bacterial Agents Language: En Journal: Antimicrob Agents Chemother Year: 2022 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Teicoplanin / Anti-Bacterial Agents Language: En Journal: Antimicrob Agents Chemother Year: 2022 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos